양수천자침 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2024-2032년)

The Global Amniocentesis Needle Market was valued at USD 176.7 million in 2023 and is projected to grow at 4.9% CAGR from 2024 to 2032. A key factor driving this market is the rising prevalence of chronic conditions in pregnant women, such as diabetes, hypertension, and autoimmune disorders, which can complicate pregnancies and increase the risk of fetal health issues. These conditions, alongside a growing number of congenital disorders, are contributing to the rising demand for amniocentesis procedures, which offer critical early diagnosis and improved management of fetal health.

Technological advancements in the design and functionality of amniocentesis needles help enhance the safety and efficiency of these procedures. Modern needles have features like adjustable stoppers for precise depth control and secure connectors for syringe-based fluid extraction. These innovations help reduce risks to the fetus and surrounding tissues, thus promoting safer procedures and increasing confidence among healthcare providers. The improvements in needle design are further boosting the adoption of amniocentesis as a reliable diagnostic tool.

The amniocentesis needle market is categorized by needle length into three segments: 100 to 150 mm, smaller than 100 mm, and larger than 150 mm. The 100 to 150 mm segment dominated the market in 2023, generating USD 92.2 million in revenue. Needles in this range are ideal for accessing the amniotic sac, especially during the second trimester when the sac is positioned approximately 8 to 12 cm below the abdominal surface. These needles offer optimal depth for extracting sufficient amniotic fluid, ensuring accurate testing and minimizing procedural risks. Their precision and safety features make them a preferred choice for clinicians performing amniocentesis.

By procedure, the amniocentesis needle market includes amniocentesis, amnioreduction, fetal blood transfusions, amnioinfusion, and cordocentesis. Amniocentesis procedures represented the largest market share, accounting for 33.1% of the total in 2023. Known for its high accuracy, amniocentesis is particularly effective in providing conclusive diagnoses, such as detecting genetic conditions like Down syndrome, which screening tests cannot always confirm.

The U.S. amniocentesis needle market, valued at USD 62.6 million in 2023, continues to lead due to a higher incidence of congenital disorders and an advanced healthcare infrastructure. With an emphasis on early diagnosis and specialized prenatal care, the demand for amniocentesis is expected to remain strong in the U.S., further driving market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing number of amniocentesis procedures
    • 3.2.1.2 Growing burden of congenital disorders
    • 3.2.1.3 Rising prevalence of chronic diseases among expectant mothers
    • 3.2.1.4 Technological advancements in amniocentesis needles
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Availability of alternative methods
    • 3.2.2.2 Dearth of skilled professionals
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy outlook

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 100 to 150 mm
• 5.3 Smaller than 100 mm
• 5.4 Larger than 150 mm

Chapter 6 Market Estimates and Forecast, By Procedure, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Amniocentesis procedures
• 6.3 Amnioreduction procedures
• 6.4 Fetal blood transfusions
• 6.5 Amnioinfusion procedures
• 6.6 Cordocentesis procedures

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Diagnostic centers
• 7.4 Clinics
• 7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Becton, Dickinson and Company
• 9.2 Biopsybell
• 9.3 Cardinal Health
• 9.4 Eurosurgical
• 9.5 Laboratoire CCD
• 9.6 M.D.L
• 9.7 McKesson Corporation
• 9.8 Medax
• 9.9 Medline Industries
• 9.10 Moller Medical
• 9.11 RI.MOS
• 9.12 Roko
• 9.13 Suzhou Leapmed Healthcare Corporation
• 9.14 The Cooper Companies
• 9.15 Vigeo